WithdrawnNot Applicable

3D-Printed Aerosolized Medication Delivery Assist Device in Patients With Chronic Respiratory Diseases

Stopped: Due to persistent challenges in participant recruitment, the study has been terminated and the protocol has been formally withdrawn.

Taiwan0Started 2024-03-28

Plain-language summary

The purpose of this study is to investigate the auxiliary benefits of three-dimensional printed activating assistive devices for soft-mist inhaler on patients' utilization habit.

Who can participate

Age range45 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 45-80 years * Patients diagnosed with chronic respiratory diseases requiring the use of SMI medication by a physician * Signed informed consent form Exclusion Criteria: * Not a first-time user of SMI medication * Requires assistance from others (primary caregiver or nurse) for the operation of SMI medication * Refusal to participate in the trial

What they're measuring

satisfaction survey

Timeframe: 1 month after the intervention

Trial details

NCT IDNCT06315374

SponsorFu Jen Catholic University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-31

View on ClinicalTrials.gov More Chronic Pulmonary Disease trials